A recent JAMA Network Open study analyzed mothers who tested positive for SARS-CoV-2 during pregnancy and the neurodevelopmental outcomes, such as motor function and speech disorders, in their...
An annual CDC report that measures HIV diagnoses found a disquieting 17% reduction in diagnoses during the first year of the coronavirus pandemic. Data from 2020 showed that 30,635 people had been...
GE Healthcare will invest up to $50 million in start-up Pulsenmore to accelerate the global adoption of ultrasound solutions and pursue FDA clearance and commercial expansion.
The companies will also...
FDA recently warned the public of the risk of false results, inappropriate use, and interpretation of results with non-invasive prenatal screening (NIPS) tests.
NIPS tests look for signs of...
Results from a long-term study conducted in Denmark show that the popular diabetes drug — metformin — is linked to an increased rate of severe birth defects. Using nearly 20 years of health...
Alife Health recently raised $22 million in Series A financing to advance in-vitro fertilization (IVF) through artificial intelligence (AI) tools.
Alife will bring its first two products...
The global hormonal contraceptive industry generated $15.02 billion in 2020 and is anticipated to generate $20.67 billion by 2030, according to a recent Allied Market Research...
Posterity Health recently launched Project AIM (Access to care-Inclusion of the Male partner), a nationwide initiative that provides men with at-home testing and access to male fertility...
Obvio Health and Renovia recently completed the first fully virtual urogynecology clinical trial, which validated the efficacy of Renovia's leva Pelvic Health System on women's urinary...
